n this episode, Director of Engineering and Project Management, Mark Taylor, discusses the project execution, challenges, achievements and success with a global pharmaceutical company whose goal was to scale up their manufacturing operations in the US and Europe for an approved CAR-T product. Specifically, the client was establishing internal lentivirus production capabilities, starting with a fast-track clinical facility at the one of their existing sites. In addition to the demand for clinical capabilities, a 200L commercial operation was also required. Both projects were schedule driven. The client chose G-CON’s POD technology for the clinical portion due to its higher probability of success in schedule driven projects.
New episodes are available every two weeks.
Visit our website at www.gconbio.com